Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada

Bristol-Myers Squibb (BMS)

Status: Completed

Conditions: Head and Neck Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT02705833

CA209-551

Details and patient eligibility

About

The primary objective of the study is to characterize the medical management of squamous cell carcinoma head and neck (SCCHN) patients diagnosed with recurrent/metastatic (R/M) disease (between 01July2013 and 30 June 2014) in the real-world setting.

Enrollment: 591 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patient (18 years old or older) with a confirmed diagnosis or R/M head and neck, may be living or deceased at time of enrollment in the study
• Diagnosis of R/M head and neck cancer between 01July2013 and 30June2014 (study index period)

Exclusion criteria

• If female patient, pregnant or lactating between 01July2013 and 30June2014
• Enrolled in cancer treatment-clinical trials since diagnosis of R/M head and neck cancer during the study index period

Trial design

591 participants in 1 patient group

Population with R/M SCCHN

Description:

Recurrent/Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) patients diagnosed between 01July2013 and 30June2014, alive or deceased, at the time of data collection